Metabolomics Insights into Activated Redox Signaling and Lipid Metabolism Dysfunction in Chronic Kidney Disease Progression

Overview

Journal Redox Biol

Specialties Biology
Cell Biology
Endocrinology

Date 2016 Oct 18

PMID 27750081

Citations 74

Authors

Hua Chen

Gang Cao

Dan-Qian Chen

Ming Wang

Nosratola D Vaziri

Zhi-Hao Zhang

Jia-Rong Mao

Xu Bai

Ying-Yong Zhao

Affiliations

Soon will be listed here.

Abstract

Early detection is critical in prevention and treatment of kidney disease. However currently clinical laboratory and histopathological tests do not provide region-specific and accurate biomarkers for early detection of kidney disease. The present study was conducted to identify sensitive biomarkers for early detection and progression of tubulo-interstitial nephropathy in aristolochic acid I-induced rats at weeks 4, 8 and 12. Biomarkers were validated using aristolochic acid nephropathy (AAN) rats at week 24, adenine-induced chronic kidney disease (CKD) rats and CKD patients. Compared with control rats, AAN rats showed anemia, increased serum urea and creatinine, progressive renal interstitial fibrosis, activation of nuclear factor-kappa B, and up-regulation of pro-inflammatory, pro-oxidant, and pro-fibrotic proteins at weeks 8 and 12. However, no significant difference was found at week 4. Metabolomics identified 12-ketodeoxycholic acid, taurochenodesoxycholic acid, LPC(15:0) and docosahexaenoic acid as biomarkers for early detection of tubulo-interstitial nephropathy. With prolonging aristolochic acid I exposure, LPE(20:2), cholic acid, chenodeoxycholic acid and LPC(17:0) were identified as biomarkers for progression from early to advanced AAN and lysoPE(22:5), indoxyl sulfate, uric acid and creatinine as biomarkers of advanced AAN. These biomarkers were reversed by treatment of irbesartan and ergone in AAN rats at week 24 and adenine-induced CKD rats. In addition, these biomarkers were also reversed by irbesartan treatment in CKD patients.

Citing Articles

Integrating bioinformatics and metabolomics to identify potential biomarkers of hypertensive nephropathy.

Yang K, Zhang P, Ding X, Yu G, Liu J, Yang Y Sci Rep. 2025; 15(1):7437.

PMID: 40032896 PMC: 11876634. DOI: 10.1038/s41598-025-89601-0.

Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomes.

Beikoghli Kalkhoran S, Basalay M, He Z, Golforoush P, Roper T, Caplin B Basic Res Cardiol. 2024; 119(6):937-955.

PMID: 39472324 PMC: 11628583. DOI: 10.1007/s00395-024-01086-6.

Daily koumiss has positive regulatory effects on blood lipids and immune system: A metabolomics study.

Wang L, Sun Y, Du L, Wang Q, Zhan M, Li S Heliyon. 2024; 10(16):e36429.

PMID: 39253138 PMC: 11382052. DOI: 10.1016/j.heliyon.2024.e36429.

Lipidomic and transcriptomic profiles provide new insights into the triacylglycerol and glucose handling capacities of the Arctic fox.

Zhu Y, Yuan Y, Si H, Li S, Zhao F, Mu R Front Vet Sci. 2024; 11:1388532.

PMID: 38988981 PMC: 11233799. DOI: 10.3389/fvets.2024.1388532.

Adenine-induced animal model of chronic kidney disease: current applications and future perspectives.

Yang Q, Su S, Luo N, Cao G Ren Fail. 2024; 46(1):2336128.

PMID: 38575340 PMC: 10997364. DOI: 10.1080/0886022X.2024.2336128.

References

Hood C, Wolley M, Kam A, Kendrik-Jones J, Marshall M . Feasibility study of colestipol as an oral phosphate binder in hemodialysis patients. Nephrology (Carlton). 2015; 20(4):250-6. DOI: 10.1111/nep.12388. View

Zhao Y, Liu J, Cheng X, Bai X, Lin R . Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta. 2012; 413(5-6):642-9. DOI: 10.1016/j.cca.2011.12.014. View

Zhao Y, Cheng X, Wei F, Xiao X, Sun W, Zhang Y . Serum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Biomarkers. 2011; 17(1):48-55. DOI: 10.3109/1354750X.2011.637180. View

Wong J, Piceno Y, DeSantis T, Pahl M, Andersen G, Vaziri N . Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014; 39(3):230-237. PMC: 4049264. DOI: 10.1159/000360010. View

Zhao Y, Feng Y, Bai X, Tan X, Lin R, Mei Q . Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One. 2013; 8(3):e59617. PMC: 3608665. DOI: 10.1371/journal.pone.0059617. View

Zhao Y, Wu S, Liu S, Zhang Y, Lin R . Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem Biol Interact. 2014; 220:181-92. DOI: 10.1016/j.cbi.2014.06.029. View

Zhao Y, Lin R . UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact. 2014; 215:7-16. DOI: 10.1016/j.cbi.2014.02.014. View

Zhao Y, Vaziri N, Lin R . Lipidomics: new insight into kidney disease. Adv Clin Chem. 2015; 68:153-75. DOI: 10.1016/bs.acc.2014.11.002. View

Wu J, Liu X, Fan J, Chen W, Wang J, Zeng Y . Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway. Toxicology. 2014; 318:22-31. DOI: 10.1016/j.tox.2014.01.008. View

10.

Vaziri N, Wong J, Pahl M, Piceno Y, Yuan J, DeSantis T . Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2012; 83(2):308-15. DOI: 10.1038/ki.2012.345. View

11.

Zhao Y, Lei P, Chen D, Feng Y, Bai X . Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE. J Pharm Biomed Anal. 2013; 81-82:202-9. DOI: 10.1016/j.jpba.2013.03.028. View

12.

Karnovsky A, Weymouth T, Hull T, Tarcea V, Scardoni G, Laudanna C . Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics. 2011; 28(3):373-80. PMC: 3268237. DOI: 10.1093/bioinformatics/btr661. View

13.

Zhao Y, Cheng X, Wei F, Bai X, Tan X, Lin R . Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E). J Proteome Res. 2012; 12(2):692-703. DOI: 10.1021/pr3007792. View

14.

Zhao Y, Cheng X, Vaziri N, Liu S, Lin R . UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry. Clin Biochem. 2014; 47(15):16-26. DOI: 10.1016/j.clinbiochem.2014.07.019. View

15.

Zhao Y, Cheng X, Cui J, Yan X, Wei F, Bai X . Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm. Clin Chim Acta. 2012; 413(19-20):1438-45. DOI: 10.1016/j.cca.2012.06.005. View

16.

Mosinska P, Storr M, Fichna J . The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective. Therap Adv Gastroenterol. 2015; 8(5):278-84. PMC: 4530433. DOI: 10.1177/1756283X15587866. View

17.

Xia J, Wishart D . MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 2010; 38(Web Server issue):W71-7. PMC: 2896187. DOI: 10.1093/nar/gkq329. View

18.

Zhang Z, Wei F, Vaziri N, Cheng X, Bai X, Lin R . Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Sci Rep. 2015; 5:14472. PMC: 4585987. DOI: 10.1038/srep14472. View

19.

Levi M . Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease). Hypertension. 2016; 67(6):1080-4. PMC: 5291829. DOI: 10.1161/HYPERTENSIONAHA.115.06417. View

20.

Weiss R, Kim K . Metabolomics in the study of kidney diseases. Nat Rev Nephrol. 2011; 8(1):22-33. DOI: 10.1038/nrneph.2011.152. View